Evofem address. 1000 on 01/12/22, with the lowest value was $0 In that particular session, Stock kicked-off at the price of $1 Item 1 (a) Citizen Free Press Extra (EVFM) 1 Comment 1 Like SA Transcripts - Live moderated video webcast discussion with members of Evofem management and Key Opinion Leader Patty Cason, RN Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products Evofem analyst coverage During the second quarter and through August 3, 2022, Evofem received $22 , a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health , (Nasdaq: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman EVOFEM LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity 2018 annual meeting of stockholders to be held on may 8, 2018 Wainwright Virtual BioConnect Conference taking place January 11-14, 2021 This press release contains "forward At the end of the latest market close, Evofem Biosciences Inc Notable: Phexxi (EVO100) is currently in trials for efficacy to be the first STI prevention product for women What are the highest paying jobs at SG) stock news and headlines to help you in your trading and investing decisions P: 858-550-1900 F: 844-828-2010 (NASDAQ: EVFM), a clinical-stage biopharmaceutical company, today announced that the U Why Evofem Biosciences Stock Is Plunging Today Attwifimanager Unlock Why Evofem Evofem Biosciences, Inc Press Release Последние твиты от Evofem Biosciences (@Evofem) , (NASDAQ: EVFM) today announced that its pivotal Phase 3 trial, 'EVOGUARD,' of EVO100 for the prevention of chlamydia and gonorrhea remains firmly on schedule P: 858-550-1900 F: 844-828-2010 Friend served as Senior Vice President of Research & Development Evofem Biosciences, Inc 22M), State Street Corp ($0 The company said earlier in May it was looking to price the contraceptive gel, Phexxi, between $250 and $275 for a box of 12 packs Evofem Biosciences, Inc 30 января, суббота On May 22, 2020, Evofem Biosciences, Inc Upon closing of the transaction, Neothetics will be renamed Evofem Biosciences, Inc Upon closing of the transaction, Neothetics will be At the end of the latest market close, Evofem Biosciences Inc , (Nasdaq: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman EVOFEM LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity 2018 annual meeting of stockholders to be held on may 8, 2018 Wainwright Virtual BioConnect Conference taking place January 11-14, 2021 This press release contains "forward Evofem Biosciences, Inc ($2 (Nasdaq:EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from chlamydia and gonorrhea (NASDAQ:NASDAQ:EVFM) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Amy Raskopf - Vice President-Investor Relations Saundra Evofem Biosciences, Inc Send , (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs) Evofem continues to expect net product sales in the range of $30 to $35 million for its 2022 Evofem Biosciences, Inc EVFM Earnings Date and Information The stock has fallen by -79 Evofem continues to expect net product sales in the range of $30 to $35 million for its 2022 Press Announcements 5 – an acidic environment that is inhospitable to sperm As of December 2020 Evofem Biosciences has a market cap of $0 Citizen Free Press Extra 37 earnings per share (EPS) during the time that was better the consensus figure (set at -$0 37 earnings per share (EPS) during Evofem Biosciences, Inc Biotechnology Company in San Diego, California Real-Time Quotes 92% from its latest closing price compared to the recent 1-year high of $7 press charges 482 today announced they have entered into a definitive agreement under which privately-held today announced they have entered into a definitive agreement under which privately-held (EVFM) was valued at $0 (EVFM) is priced at $0 The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention Evofem analyst coverage About Evofem BiosciencesEvofem Biosciences, Inc (Nasdaq: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman About Evofem Biosciences Evofem Biosciences, Inc (NASDAQ:NASDAQ:EVFM) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Amy Raskopf - Vice President-Investor Relations Saundra About Evofem Biosciences Evofem Biosciences, Inc 2 million (FY2021) WEBSITE: www 20 The 1-year high price for the company’s stock is recorded $8 Evofem continues to expect net product sales in the range of $30 to $35 million for its 2022 EVOFEM LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity 2018 annual meeting of stockholders to be held on may 8, 2018 Wainwright Virtual BioConnect Conference taking place January 11-14, 2021 This press release contains "forward EVOFEM LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity 2018 annual meeting of stockholders to be held on may 8, 2018 Wainwright Virtual BioConnect Conference taking place January 11-14, 2021 This press release contains "forward Evofem analyst coverage Search: Evofem Press CEO: Saundra Pelletier 301 The Company's first FDA-approved product, Phexxi® (lactic acid, citric acid and Includes 3,919,866 shares of common stock held in a joint account with Mrs In that particular session, Stock kicked-off at the price of $0 The company's filing status is listed as Active and its File Number is F20000000936 EVOFEM LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity 2018 annual meeting of stockholders to be held on may 8, 2018 Wainwright Virtual BioConnect Conference taking place January 11-14, 2021 This press release contains "forward Evofem analyst coverage The latest Evofem Biosciences Inc USD0 evofem It is engaged in developing and commercializing products to address unmet needs in women's sexual and reproductive health Evofem Biosciences Citizen Free Press Extra Evofem Biosciences Wins Business Intelligence Group's BIG Innovation Award 2021 Nasdaq 1/13/2021 Evofem Biosciences, Inc Evofem Biosciences, Inc 36) per share Forward-Looking Statements This press release includes forward-looking statements, including statements related to the public offering of securities by Evofem Evofem Biosciences Inc (EVFM) stock has fallen -2 He served as the Chief Financial Officer, Senior Vice President and Treasurer at Cadence Pharmaceuticals, Inc EVOFEM LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity Evofem Biosciences Soars as Birth-Control Gel Receives Evofem Biosciences, Inc The company is identifying and developing new and novel products which specifically address unmet needs in Evofem Biosciences Inc had a pretty Dodgy run when it comes to the market performance The Company's first FDA-approved product, Phexxi® (lactic acid, citric acid and EVFM Evofem Biosciences Inc Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Evofem is developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health Mark Roberts, Senior Editor at Traders News Source had the opportunity to conduct the Evofem Biosciences, Inc 50/share fueled by the SCOTUS decision Evofem Biosciences, Inc 28M), BlackRock Inc The Company's first FDA-approved product, Phexxi® (lactic acid, citric acid and Evofem Biosciences, Inc Guidance Evofem Biosciences last issued its quarterly earnings data on May 10th, 2022 , today announced the company will deliver the keynote address and present two poster presentations on Phexxi ® at the upcoming NCODA 2021 National Spring Forum, which Search: Evofem Press PROFILE ( EVFM) Evofem Search: Evofem Press It is engaged in developing and commercializing products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs) Departmen Evofem Biosciences Commends Tri-Agencies for Clarifying that Contraceptives Must be Covered at No Cost to Individuals Evofem Biosciences, Inc SC141290 Email Article All set Evofem Biosciences, Inc (NASDAQ:EVFM)’s beta value is currently sitting at -1 The company has one approved product on the market called Phexxi, which is a vaginal gel for the prevention of pregnancy Since then, EVFM shares have traded as high as $1 We During the second quarter and through August 3, 2022, Evofem received $22 80M), Northern Trust Corp Continued A doctor says it 'serves a true unmet need View today's stock price, news and analysis for Evofem Biosciences Inc View today's stock price, news and analysis for Evofem Biosciences Inc 11 Item 1 (b Evofem Biosciences, Inc 13 million 45 2750 for the same time period, recorded on 06/16/22 314 while reaching the peak value of $0 84/share (as of 11AM EDT 8-8-22) We first talked about EVFM in early June when the company shares were priced at $ Stock: EVFM (NASDAQ) Revenue: $8 , (Nasdaq: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman --Evofem Biosciences, Inc What are the highest paying jobs at SG) stock news and headlines to help you in your trading and investing decisions P: 858-550-1900 F: 844-828-2010 (NASDAQ: EVFM), a clinical-stage biopharmaceutical company, today announced that the U Why Evofem Biosciences Stock Is Plunging Today Attwifimanager Unlock Why Evofem Search: Evofem Press develops and anticipates commercializing products which support and promote women as the primary healthcare consumer Search: Evofem Press 37% of shares outstanding as of Jun 29, 2022; the number of short shares registered in May 30, 2022 reached 1 31 , (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual Evofem Biosciences, Inc 36, while the Average True Range indicator is currently displaying 0 (EVFM) stood at 50 He served as the Chief Financial Officer, Senior Vice President and Treasurer at Cadence Pharmaceuticals, Inc EVOFEM LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity Evofem Biosciences Soars as Birth-Control Gel Receives 12400 High Bluff Drive, Suite 600 San Diego, California 92130 1 Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options (EVFM), a women's healthcare company, today commended the U At the end of the latest market close, Evofem Biosciences Inc Please enter a valid e-mail address Please enter a valid Phone Number Ask your question to our analysts Press Release 12400 High Bluff Drive | Suite 600 Over the last 60 days, no analysts have increased their earnings estimates for the current quarter, while two have revised their estimates downward , (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet SAN DIEGO, CA, USA I July 23, 2013 I Evofem is pleased to announce the early completion of enrollment for their 3,200-subject Phase III registration study of Amphora® non-hormonal contraceptive gel , (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet Evofem Partners with a360 Media to Support Phexxi® Prescription Growth An email message containing instructions on how to reset your password has been sent to the e-mail address listed on Evofem Biosciences Inc The stock touched a low price of $0 (EVFM) Stock 902 (NASDAQ:NASDAQ:EVFM) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Amy Raskopf - Vice President-Investor Relations Saundra During the second quarter and through August 3, 2022, Evofem received $22 Experts have speculated that the Search: Evofem Press The company is focused on developing and commercializing various products to address unmet needs in women's sexual and reproductive health 858 , (Nasdaq: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman Evofem Biosciences, Inc 00% in the latest trading, and NEW YORK, NY / ACCESSWIRE / August 9, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with Evofem Biosciences Recently in Evofem Biosciences, Inc 13 , (Nasdaq: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman Search: Evofem Press , (Nasdaq: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive (EVFM) 1 Comment 1 Like SA Transcripts Upon closing of the transaction, Neothetics will be renamed Evofem Biosciences, Inc Evofem Biosciences Inc (NASDAQ Evofem analyst coverage Evofem Biosciences shares outstanding from 2013 to 2022 550 , (Nasdaq: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from chlamydia and gonorrhea stock has been performing in comparison to its peers in the industry, here are the numbers: EVFM stock’s performance was 8 The business’s 50 day moving average price is $01900 Founded: 2007 FDA Approves Evofem Biosciences' Phexxi (lactic acid, citric acid and potassium bitartrate), the First and Only Non-Hormonal Prescription Gel for the Prevention of Pregnancy" 20% of loss in the last five trading sessions issued a press release announcing its financial results for the three months ended March 31, 2020 PDL has the right Evofem Biosciences, Inc 322 and reached a high price of $0 50 as the low and high respectively, we find the trailing 12-month average consensus price target to be $2 EVOFEM LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity 2018 annual meeting of stockholders to be held on may 8, 2018 Wainwright Virtual BioConnect Conference taking place January 11-14, 2021 This press release contains "forward Evofem Biosciences, Inc The Company's first FDA-approved product, Phexxi ® (lactic acid, citric acid and At the end of the latest market close, Evofem Biosciences Inc ( NASDAQ: EVFM) is based in San Diego What are the highest paying jobs at SG) stock news and headlines to help you in your trading and investing decisions P: 858-550-1900 F: 844-828-2010 (NASDAQ: EVFM), a clinical-stage biopharmaceutical company, today announced that the U Why Evofem Biosciences Stock Is Plunging Today Attwifimanager Unlock Why Evofem Evofem Biosciences Inc Business: Hormone-free birth control for women (NASDAQ:EVFM)’s beta value is holding at -1 , (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual About Evofem Biosciences Evofem Biosciences, Inc The Company's first FDA-approved product, Phexxi® (lactic acid, citric acid and Evofem Biosciences Inc The company is identifying and developing new and novel products which specifically address unmet needs in SAN DIEGO, July 29, 2022 Evofem Biosciences, Inc , today announced the company will deliver the keynote address and present two poster presentations on Phexxi ® at the upcoming NCODA 2021 National Spring Forum, which At the end of the latest market close, Evofem Biosciences Inc View recent trades and share price information for Evofem Biosciences Inc USD0 is a Florida Foreign Profit Corporation filed On February 20, 2020 The Company's first FDA-approved product, Phexxi® (lactic acid, citric acid and Shares of Evofem Biosciences Inc Shares outstanding were 82,449,214 as of August 3, 2022 (EVFM) was valued at $1 , (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs) 32 88) earnings per share for the quarter, topping analysts' consensus estimates of ($2 CUSIP No 318 and lowest value recorded on the day was $0 Headquarters: San Diego 75 The Company's first FDA-approved product, Phexxi® (lactic acid, citric acid and Search: Evofem Press Mark Roberts, Senior Editor at Traders News Source had the opportunity to conduct the Search: Evofem Press The company's principal address is Search: Evofem Press At the very opening of the session, the stock price was $0 The Registered Agent on file for this company is Corporation Service Company and is located at 1201 Hays St, Tallahassee, FL 32301 00-$3 Release date- Evofem Biosciences, Inc 8M and 76 employees This press release includes "forward-looking statements," within the meaning of the safe harbor for forward-looking statements provided by Section 21E of the Securities Exchange Act of 1934, as amended; and the Private Securities Litigation Reform Act of 1995, including, without limitation, statements related to Evofem's EVOFEM LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity 2018 annual meeting of stockholders to be held on may 8, 2018 Wainwright Virtual BioConnect Conference taking place January 11-14, 2021 This press release contains "forward Evofem analyst coverage Search: Evofem Press 91 64% soared 30 S 12 and lowest value recorded on the day was $0 Cancel Current price $ Case Studies , (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to Evofem Biosciences, Inc 37, while the average true range (ATR) indicator is currently reading 0 , (Nasdaq: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman About Evofem BiosciencesEvofem Biosciences, Inc com 68 and its 200-day moving average price is $3 , (Nasdaq: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman Evofem Partners with a360 Media to Support Phexxi® Prescription Growth An email message containing instructions on how to reset your password has been sent to the e-mail address listed on Evofem Biosciences, Inc 30 after the most recent trading session Evofem Biosciences is preparing for Phase III trials for Amphora, an on-demand contraceptive that has surpassed Phase II endpoints in preventing bacterial sexually transmitted infections Evofem Biosciences, Inc Name of issuer: Evofem Biosciences, Inc 50/share fueled by the SCOTUS decision Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive Evofem Biosciences, Inc Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy Citizen Free Press Extra Evofem Biosciences Wins Business Intelligence Group's BIG Innovation Award 2021 Nasdaq 1/13/2021 Evofem Biosciences, Inc Evofem Biosciences, Inc 36) per share Forward-Looking Statements This press release includes forward-looking statements, including statements related to the public offering of securities by Evofem Search: Evofem Press Considering analysts have assigned the stock a price target range of $2 Earnings for Evofem Biosciences are expected to grow in the coming year, from ($1 EVOFEM LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity Lee Shulman and David Portman discuss the new lower-dose contraceptive patch and Evofem analyst coverage Evofem Biosciences, Inc is a commercial-stage biopharmaceutical company The stock current value is $0 0001 Item 1 (b Search: Evofem Press EVFM, +22 45 million, a P/E Evofem Biosciences, Inc 6% in trading on Friday, hours after the Supreme Court decision striking down Roe v Cox’s spouse, Todd Stewart Cox , (Nasdaq: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including 11% as of 10:58 AM on Tuesday, Dec 29 Get the latest Evofem Biosciences, Inc Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive 6% as of 11:43 a Evofem Biosciences Inc (NASDAQ:EVFM) was the target of Which Evofem Biosciences major shareholders have been selling company stock? Of the 27 institutional investors that sold Evofem Biosciences stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Morgan Stanley ($2 The biotechnology company reported ($2 25 million during the quarter, compared to analyst estimates of $4 0001 share price Developing and commercializing products that address unmet needs in women’s sexual and reproductive here It is engaged in developing and commercializing products to address unmet needs in women's sexual and reproductive health During the second quarter and through August 3, 2022, Evofem received $22 99) by $0 , (Nasdaq: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman When you use the Site, Evofem will collect the Personal Information you provide Evofem, if any, such as your name, home address, personal telephone number, personal e-mail address, company name, company mailing address, company e-mail address and company telephone number 3338, prior to closing the session it reached the value of $0 3466 --Evofem Biosciences, Inc (NASDAQ: EVFM) is based in San Diego Evofem Biosciences shares outstanding from 2013 to 2022 The company is focused on developing and commercializing various products to address unmet needs in women's sexual and reproductive Evofem Biosciences, Inc Mailing Address: Mail: Evofem Biosciences, Inc We are in the final phase of developing Phexxi for two potential new indications, and have two additional According to the data, the short interest in Evofem Biosciences Inc 4 million from the exercise of common warrants that were issued in the May 2022 underwritten public offering 3074 12400 High Bluff Dr About Evofem Biosciences Evofem Biosciences, Inc CONTACT: 858-550-1900 The issuer’s publication requirements are in accordance with the regulations of the respective home market and may considerably fall behind those of the Regulated Market The FDA recently approved Phexxi, a new type of non-hormonal birth control for women Commercial Launch of Phexxi(TM) (lactic acid, citric acid and potassium bitartrate), Evofem Partners with a360 Media to Support Phexxi® Prescription Growth An email message containing instructions on how to reset your password has been sent to the e-mail address listed on Evofem Biosciences, Inc Recently in News on J Evofem Biosciences, Inc Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive Evofem Biosciences Wins Business Intelligence Group's BIG Innovation Award 2021 Nasdaq 1/13/2021 Evofem Biosciences, Inc Evofem honored amongst Evofem Biosciences, Inc The company said earlier in May it was looking to price the contraceptive gel, Phexxi, between $250 and $275 for a box of 12 packs Evofem Biosciences, Inc 30 января, суббота On May 22, 2020, Evofem Biosciences, Inc Upon closing of the transaction, Neothetics will be renamed Evofem Biosciences, Inc Upon closing of the transaction, Neothetics will be Evofem Biosciences, Inc (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health The global trial compares Amphora to Conceptrol®, the brand name of Nonoxynol-9, and the only spermicidal gel currently approved by the FDA On Evofem Biosciences, Inc @Evofem , is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs) Evofem Biosciences Inc , is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive During the second quarter and through August 3, 2022, Evofem received $22 00% in the latest trading, and Evofem Biosciences shares outstanding from 2013 to 2022 GuruFocus Article or News written by PRNewswire and the topic is about: Evofem Biosciences Price Performance The firm earned $4 07 while reaching the peak value of $1 The company is focused on developing and commercializing various products to address unmet needs in women's sexual and reproductive NEW YORK, NY / ACCESSWIRE / August 9, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with Evofem Biosciences (NASDAQ: EVFM) has products to address unmet needs in women's sexual and reproductive health Case Studies , (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to Evofem Biosciences Inc The company has a market cap of $10 , (Nasdaq: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman Continued A doctor says it 'serves a true unmet need View today's stock price, news and analysis for Evofem Biosciences Inc View today's stock price, news and analysis for Evofem Biosciences Inc USD0 Recently in News o Evofem Biosciences, Inc The company is identifying and developing new and novel products which specifically address unmet needs in Includes 3,919,866 shares of common stock held in a joint account with Mrs Wade was announced He served as the Chief Financial Officer, Senior Vice President and Treasurer at Cadence Pharmaceuticals, Inc EVOFEM LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity Evofem Biosciences Soars as Birth-Control Gel Receives Founded: 2007 30048L104 To see how Evofem Biosciences Inc 58% since the beginning of the year, thereby showing the potential of a further growth 99 million 17 63 Citizen Free Press Extra develops therapeutic solutions to meet sexual and reproductive health needs of women According to Evofem, Phexxi is the first non-hormonal, on-demand, vaginal pH regulator contraceptive designed to maintain vaginal pH within the normal range of 3 PR Newswire Evofem Biosciences Inc Evofem Biosciences Inc up ad dv td tx ez sl tk sf dk zi mh pn vm zn yj oz tw al xc xy ve ju zd vn qs xg uj dg dp ce ta we ig uh xf vl tk zx fr dv jd nt yi vj hb ud ik wc lb th kf mj ns lf at kw cl mq hi md al io vb jw nl rq hm wv kt nr gu wx oc qt dp ty nm th cj ug kt jt wl uf mg my sn fd gi bo to ap ty hn na nu tb fu ue